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Summary 
CD4 + T  helper (Th) cells can be classified into different types based on their cytokine profile. 
Cells with these polarized patterns of cytokine production have been termed Thl  and Th2, 
and can be distinguished functionally by the production oflFN-~/and IL-4, respectively. These 
phenotypes are crucial in determining the type of immune response that develops after antigen 
priming. There are no surface markers that define them, and cytokine immunoassay or mR.NA 
analysis both have limitations for characterization of single cells. Using immunofluorescent de- 
tection of intracellular IFN-~/and IL-4, we have studied the emergence of Thl and Th2 cells 
in response to  antigen exposure and the patterns  of cytokine synthesis in  established T  cell 
clones. IFN-~ production by Thl clones was detectable in almost all cells by 4 h, and it contin- 
ued in most cells for >24 h. IL-4 production in Th2 cells peaked at 4 h, but declined rapidly. 
In Th0 cells containing both cytokines, fewer cells produced IFN-% which did not appear un- 
til IL-4 synthesis declined. Cocultivation of clones showed no such cross-regulation. Antigen 
stimulation of transgenic T  cells  expressing an ovalbumin-specific T  cell receptor generated 
Th2 cells, probably as a result of endogenous IL-4 production. Addition of IL-12 and/or anti- 
IL-4 caused Thl  cells  to  develop, while some Th0  cells  were seen when  IL-12 alone was 
added. These results show that stimulation in the presence of polarizing stimuli results  in cells 
producing either IFN- T or IL-4, but that coproduction can occur in rare cells under defined 
conditions. 
C  D4  Th cells can be classified into different types that 
produce characteristic clusters of cytokines, some di- 
recting  cell-mediated  immune  responses  and  others  en- 
hancing  antibody production by B  cells  (1--4).  Thl  cells 
produce IL-2, IFN-',/, and lymphotoxin, and they promote 
delayed-type hypersensitivity responses; Th2 cells produce 
other  cytokines, including  IL-4,  IL-5,  IL-10,  and  IL-13, 
which direct allergic or antiinflammatory responses, as well 
as provide help for some B  cell responses  (2-5).  Th cells 
producing cytokines typical of both Thl  and Th2 clones 
have also been described in murine and human systems (2- 
4, 6-8). These have been called Th0 cells, and they may be 
precursors of the polarized Thl  and Th2 phenotypes (9). 
Alternatively, Th0 cells may represent a separate, stably dif- 
ferentiated population under some conditions.  It is possi- 
ble, for example, that Th0 cells are instrumental in elimi- 
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nating some pathogens, where the correct balance of cell- 
mediated  and  humoral  immunity can  clear the  organism 
with  minimum  immunopathology.  By contrast,  in  many 
chronic conditions, polarized Thl- or Th2-type immune 
responses  emerge that  are  mutually exclusive, perhaps  in 
part because of counter-inhibitory effects of cytokines on 
the reciprocal Th subsets  (10-14). The cytokine most char- 
acteristic of Thl responses is IFN-~/, a major component of 
the cell-mediated immune response that is essential  for the 
elimination of Leishmania  major in mice resistant to infec- 
tion (15-17).  Conversely, IL-4 production can be used to 
define the Th2 response that renders BALB/c mice suscep- 
tible to L. major (18,  19). 
Polarized populations of CD4 + Thl- and Th2-type cells 
can be induced to develop from naive T  cells by stimula- 
tion in the presence of particular cytokines (20-22).  Th2 
cells develop when naive T  cells are stimulated with either 
mitogen or specific antigen in  the  presence of IL-4  (23- 
26).  Conversely, IL-12 is a dominant factor in driving the 
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CD4 + T  cells  (27-29). 
To date, most studies ofcytokine production by Th cells 
have used immunoassays or mRNA analysis, neither of  which 
give simultaneous information about production of differ- 
ent cytokines from individual cells. Recently, attempts have 
been made to analyze cytokine production by mouse T  cell 
clones (30) and by mouse or human peripheral T  cells  (31- 
36), in most cases using flow cytometry. We have used this 
method  to  examine  the  patterns  of cytokine  synthesis  in 
Thl, Th2, and Th0 populations derived from naive CD4 § 
T  cells  stimulated  repeatedly  with  antigen,  and  we  have 
compared IFN-~ and IL-4 production patterns of individ- 
ual  cells  with  established  clones  derived  from  single-cell 
cultures. This study shows that IL-12 or IL-4 can direct the 
development  of cells  producing  IFN-~  or  IL-4 alone,  as 
well as cells producing both cytokines simultaneously, such 
that the pattern  of cytokine production by individual  cells 
in the population resembles that of established Th cell clones. 
Materials and Methods 
Animals.  Mice  transgenic  for the DOll.10  TCR-ct[3 on a 
BALB/c genetic background (37) were identified at  the age  of 
4--6 wk by staining  peripheral  blood leukocytes with  the anti- 
TCR clonotype-specific mAb KJ1-26  (38). All transgenic  mice 
used were heterozygous for the TCR-et and -[3 transgenes.  Fe- 
male  nontransgenic BALB/c  mice between  6-10 wk old were 
purchased from Simonsen Labs (Gilroy, CA). 
Th Cell Clones.  Stimulation  and maintenance of  long-term Th 
clones was as previously described: Thl, HDK1 (BALB/c-derived, 
KLH-specific,  I-A  d  restricted)  (39);  Th2,  CDC25  (C3D2F1/ 
J-derived, normal rabbit IgG-specific, H-2I  d restricted (40). Short- 
term Th clones  derived from unimmunized DOll.10 TCR-~x[3 
transgenic  mice were obtained by sorting single cells on the basis 
of CD4 +, LECAM-W  ight, KJ1-26 + into 96-well microtiter wells 
containing  l0  s  irradiated  splenic  APC  (3,000  fads)  plus  OVA 
peptide (0.3 ~M) under the following conditions: Thl clones, in 
the presence of IL-2 (107 U/rag, 330 U/ml), IL-12 (10  e U/rag; 
100 U/ml plus small amounts of IL-4 that were required to main- 
tain cell viability) plus TGF-~ (2 ng/ml); Th2 clones, in the pres- 
ence of IL-2 (330 U/ml) and large amounts of IL-4 (107 U/rng, 
100 U/m]); Th0 clones, in the presence of IL-2 (330 U/m]), IL-4 
(15  U/ml),  and  IL-12  (10  U/m]).  All  the  DOll.10-derived 
clones  were  100% positive  for the  clonotype antibody KJ1-26 
(cells are referred to as clones when they have been derived from 
a single  cell in culture,  as opposed to the populations described 
below, which were not derived from single  cells in culture al- 
though they carried  the same transgene  and, thus,  antigen speci- 
ficity).  Clones were restimulated  and expanded under these  re- 
spective  conditions every 2  wk. All  clones were  expanded and 
maintained in [cRPMI 1640 (JR. Scientific  Inc., Woodland, CA) 
containing 10% FCS  (JR Scientific  Inc.), r-glutamine  (2 mM), 
penicillin  (100  U/m]),  streptomycin (100  ~g/m]),  Hepes buffer 
(10 mM), sodium pyruvate (1 raM), 2-ME (0.05 raM; Sigma)], 
and cRPMI supplemented  with mouse rlL-2  (330  U/m]),  and 
the respective  initiating  conditions were used for growth of the 
clones.  In some cases, clones  were stored in liquid nitrogen and 
cells were thawed into medium containing murine rlL-2 (330 U/ 
m]), as described  above, 5-7 d before assay. 
Rested T  cell clones  were washed,  counted, and resuspended 
at 2 ￿  10  s per well, and were restimulated with irradiated BALB/c 
(3,000  fads) splenic  APC plus  specific antigen or PMA (50 ng/ 
ml) plus ionomycin (500 ng/ml) for 4 h at 37~  with Brefeldin 
A (10 p,g/ml) added for the last 2 h (for flow cytometric analysis 
of intracellular  cytokine staining).  Identical  stimulations  of T cells 
were set up in parallel, but in the absence of  Brefeldin  A, for 48 h 
at 37~  for analysis of IL-4 and IFN-~ in supernatants  by immu- 
noassay as previously described  (41, 42). 
Culture Medium,  Cytokines,  Antibodies,  and Antigens  and  Other 
Reagents.  The  culture  medium  used  was  cR.PMI,  as  described 
above, without supplemented cytokines,  unless indicated. 
Recombinant mouse cytokines were  obtained  from the  fol- 
lowing sources: IFN-% Schering Research (Bloomfield, NJ); IL-4, 
Dr S. Menon (DNAX); TGF-~, R  & D Systems, Inc. (Minneap- 
olis, MN), and IL-2, a kind gift from Gerard Zurawski (DNAX). 
Mouse rlL-12 was obtained by transfecting  COS7 cells with the 
cDNA encoding the p35 and p40 eDNA as described  previously 
(43),  which was  obtained by PCR cloning using published  se- 
quences  (43). Supernantants  from  mock-transfected  cells were 
used as a control and showed no effect in the concentration range 
at which IL-1.2 was used.  The IL-12 content of the supernatants 
ranged from 2,000 to 10,000 U/ml (44). 
Purified rat anti-mouse IL-4 (11Bll) and anti-IFN-',/(AN18) 
antibodies  have been previously described (44,  45),  and an iso- 
type-matched control was supplied  by J. Abrams (DNAX) (42). 
The IL-12-specific mAbs C15.6.7 and C15.1.2 were as described 
(46). mAbs used for flow cytometric sorting or analysis included 
anti-mouse  CD4-PE and lectin endothelial  cell adhesion mole- 
cule-l-FITC  (both from Pharmingen,  San  Diego,  CA).  Addi- 
tional anticytokine mAbs for immunoassay  and flow cytometry, 
including  anti-mouse  IL-4  and  IFN-~/  reagents,  were  purified 
from  serum-free  hybridoma  supernatants  as  previously  de- 
cribed (42). 
The antigenic OVA peptide (OVA323..339)  from chicken oval- 
bumin was synthesized  on a peptide synthesizer  (model 430; Ap- 
plied Biosystems,  Inc.,  Foster City,  CA). KLH and rabbit  lgG, 
both from Sigma, were used at 100 and 500 p.g/ml, respectively. 
Reagents for cell cycle analysis were as follows:  100￿  propid- 
ium iodide  (PI) 1 stock: 1.0  mg/m_l PI in sodium citrate  (3.8  ￿ 
10 -2 M, pH 7.0,  stored at room temperature and protected from 
light).  40￿  RNase A,  10 mg/ml RNase A  (Sigma) in  10 mM 
Tris-HC1,  pH 7.5,  15 mM NaC1 boiled for 15 rain,  cooled to 
room temperature, and stored at -20~ 
Preparation of T  cells and APC.  CD4 + T  cells were enriched 
by  negative  selection  using  magnetic  activated  cell  sorting 
(MACS) with a cocktail ofbiotinylated anti-mouse CD8ct, I-A  a, 
B220, and Mac-1 antibodies  as previously described  (41) (Milte- 
nyi,  Sunnyvale,  CA).  T  cells staining  positive  for  CD4  and 
LECAM-1 (47) were further purified by positive selection using a 
FACStar  pluS|  flow cytometer (Becton Dickinson & Co., Moun- 
tain View, CA) to achieve 99.8% CD4 + T cells. Staining  did not 
alter the function of the T cells (not shown). 
Stimulation  of Transgenic CD4 + T  Cells for Cytokine Production. 
(a)  Primary stimulations  of CD4  + T  cells (2.5  ￿  10  s per well) 
were  earned  out  using  OVA peptide  (0.3  p.M)  and  nucleated 
spleen cells (5 ￿  106 per well, 3,000 rads) as APC in a total vol- 
ume of 2 ml in 24-weU plates. In addition, some cultures received 
cytokines (200 U/ml IL-4 or 10 U/ml IL-12) or mAbs to block 
endogenous cytokines  (10  p.g/ml  anti-IL-4).  T  cells were  ex- 
1Abbreviations used in this paper: PI, propidium iodide; OVA, antigenic 
0VA323_339  peptide. 
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(b)  Cells  were  then  harvested  on  day  6,  washed  three  times, 
counted, and resuspended at 2  ￿  105 per well,  and restimulated 
with irradiated  BALB/c splenic APC (3,000  rads) plus OVA (0.3 
~M), or PMA (50 ng/ml) plus ionomycin (500 ng/ml) for 4 h at 
37~  with Brefeldin A (10 Ixg/rul) added for the last 2 h (to en- 
hance flow cytometric analysis of intracellular  cytokine staining). 
Identical stimulations  of T cells were set up in parallel, but in the 
absence of  Brefeldin A, for 48 h at 37~  for IL-4 and IFN-~ anal- 
ysis in supematants by immunoassay as previously described (41, 42). 
Additionally,  cultures  of naive CD4  + T  cells were stimulated 
in primary cultures,  under the same conditions as described above 
(a), but in this  case, the stimulations  were repeated weekly for 
three  consecutive weeks  (chronic  stimulation)  before washing, 
harvesting,  and restimulating  as described  above (b). 
Cytokine Assays.  IFN-~/was detected using a two-site sand- 
wich ELISA (42, 44), which has a lower limit of sensitivity of 125 
pg/ml (1 U/ml =  0.1 ng/ml). The ELISA for IL-4 has been de- 
scribed previously (41, 42) with a lower limit of sensitivity of 100 
pg/ml. 
Flow Cytometric  Analysis of lntracellular IFN-T and IL-4 Synthe- 
sis.  Cells were resuspended at  10s-106/ml and stimulated  with 
PMA at 50 ng/ml plus ionomycin at 500 ng/ml. At various times 
after  stimulation  (typically  2 h  before cell harvest),  Brefeldin A 
(catalogue  no. B905MG; Epicentre Technologies Corp., Madi- 
son, WI) was added at 10 Ixg/ml using a stock of 1 mg/ml in eth- 
anol. Cells were harvested,  washed, and resuspended in PBS with 
Brefeldin A before adding an equal volume of 4% formaldehyde 
fixative  (final concentration  =  2%). After fixing for 20 rain  at 
room temperature, cells were either stored in PBS at 4~  for up 
to 2 d,  or they were stained  immediately for cytokines using a 
modified method (35, 36) based  on that described by Assenma- 
cher et al.  (33). For intraceUular staining,  all reagents  and washes 
contained 1% BSA and 0.5% saponin (S-7900;  Sigma), and all in- 
cubations were at room temperature. After washing and a 10-min 
incubation in PBS/BSA/saponin, cells were incubated with anti- 
IL-4 (11Bll) at 5 Ixg/ml or GLII3 (isotype control) at 10 I.Lg/ml 
for 30 min.  After two washes,  optimal concentrations of FITC 
anti-rat Ig (antibody raised in rabbit,  catalogue no. FI4001; Vec- 
tor Laboratories,  Burlingame, CA) were added for 30 min. After 
two washes, purified rat lg was added at 300 I~g/ml for 10 min to 
block residual anti-rat Ig binding. Without washing, anti-IFN-~/ 
(AN18-PE  or  control  PE-conjugated  rat  IgG,  catalogue  no. 
11025 A; Pharmacia Fine Chemicals,  Piscataway,  NJ) was added 
at  a final  concentration of 2.5  ~tg/ml.  After 20 min,  cells were 
washed twice with PBS/BSA/saponin and then with PBS/BSA 
without saponin to allow membrane closure.  Samples were ana- 
lyzed  on  a  FACScan  |  flow  cytometer  (Becton  Dickinson). 
Thresholds were set on control stains (included for every sample 
at every timepoint) to lie on the first percentile. Results were an- 
alyzed using Lysis II and Cellquest  softwares (Becton Dickinson). 
Cell Cycle Analysis by PI Staining.  Th clones were harvested 
(1-3  ￿  106) after  stimulation  with  PMA  and  ionomycin  (as 
above) for various time intervals.  Cells were washed twice in PBS 
and then resuspended in 1 ml PBS. The cell suspension  was then 
added to 5 ml cold ethanol  (100%) very slowly (drop by drop) 
with vortexing to prevent clumping and ensure  a single-cell  sus- 
pension. The cells were fixed in ethanol for 15 rain, and can be 
stored at 4~  for up to 2 wk. After fixation,  the cells were washed 
once with PBS and resuspended in a solution ofPl/RNase A (10 
I~g/ml PI, 250 Ixg/ml RNase A in PBS; this solution should be 
made up from stocks  directly before use).  The cells were incu- 
bated in this solution at 37~  for 30 rain and were then analyzed 
within 24 h on the FACScan  |  flow cytometer. Results were ana- 
lyzed using Cellquest software (Becton Dickinson). 
Results and Discussion 
Intracellular Synthesis of IFN-~/ and 11_,-4 are Mutually  Ex- 
clusive and Show Different Kinetics in Established Th l  and Th2 
Clones.  The aim of this study was to use flow cytometry 
to simultaneously  analyze intracellular  synthesis  of IFN-~/ 
or IL-4 by maturing T  cells obtained from naive TCR-etl3 
transgenic CD4 + T  cells stimulated with specific antigen in 
the presence oflL-4 or IL-12. In particular, it is not known 
whether  cells  within  a  Thl  or  Th2  population  produce 
IFN-~/and IL-4 exclusively, or whether they are capable of 
simultaneously  synthesizing  both  cytokines.  We  also  ad- 
dress this in Th0 clones known to produce both cytokines 
by immunoassay. To validate the method of cytokine anal- 
ysis by flow cytometry, we first studied the pattern of cyto- 
kine  staining  in  established  Thl  and  Th2  clones,  known 
only to produce each cytokine by reverse transcription PCR. 
It had been suggested that IL-4 and IFN-~/are never co- 
expressed in individual  CD4 +  T  cells  (33)  Since this con- 
clusion  may have  resulted  from limited  sensitivity  of the 
methods used, we stimulated cells in the presence of Brefel- 
din A  to disrupt the Golgi apparatus, inhibit protein secre- 
tion, and thus increase the sensitivity of cytokine detection 
(35,  36).  Flow  cytometric  analysis  of a  long-term  Thl 
clone  showed  that  disruption  of the  Golgi  complex  by 
Brefeldin A  (Fig. 1 A) caused increased sensitivity of IFN-7 
detection  (Fig.  1 /3). Brefeldin A  also enhanced senstitivity 
for  IL-4 detection  in  Th2  clones  (data  not  shown).  The 
profile  demonstrates  a  shift  in  fluorescence  of the  whole 
population, relative to control Ig staining, indicating that at 
least  95%  of the  cells  can  synthesize  IFN-  7.  In this  case, 
PMA and ionomycin were used to stimulate the Thl clone 
to circumvent heterogeneity in the kinetics ofT cell stimu- 
lation that might result from processing and presentation of 
the intact protein by APC. 
To assess  the frequency of IL-4-expressing cells in Th2 
clones  relative  to that  of IFN-7  synthesis  by Thl  clones, 
cells were stimulated with PMA and ionomycin for 24 h, 
with  Brefeldin  A  added  for the  last  2  h.  Thl  clones  in- 
cluded (a) a long-term KLH-specific clone, HDK-1  (Fig. 2 
A) (39); and (b) two freshly derived short-term Thl  clones 
obtained  from single-cell  cultures  of CD4  +  T  cells  from 
DOl1.10  TCR-cxl3  transgenic  mice  (Fig.  2,  B  and  C). 
Upon stimulation  with  PMA and  ionomycin,  79--96% of 
the Thl  clones stained positive for IFN-~/and negative for 
IL-4 relative to an isotype control.  (Fig. 2  D).  Th2 clones 
included  (a)  a  long-term  rabbit  Ig-specific  Th2  clone, 
CDC25  (Fig. 2 A) (40); and (b) two recently derived Th2 
clones obtained from single-cell cultures  of CD4 +  T  cells 
from DOl1.10  TCR-al3  transgenic  mice  (Fig.  2,  B  and 
C).  In contrast to the  synthesis  of IFN-~/by Thl  clones, 
intracellular synthesis oflL-4 could only be detected in 30- 
33% of the cells; all were negative for IFN-  7. The levels of 
cytokines measured by immunoassay in the supernatants of 
these  Thl  and Th2  clones  correlated well with  the  cyto- 
1359  Openshaw et al. Figure  1.  Enhancement  of in- 
traceUular cytokine  immunoflu- 
oresence  by  Brefeldin  A.  Thl 
cells (HDK-1)  were  stimulated 
for 4 h with PMA and ionomy- 
cin, and then  fixed and stained 
for IFN-',/ synthesis with  (A) an 
anti-IFN-y antibody (AN18) or 
a control antibody (GLl17) fol- 
lowed  by  an  anti-rat FITC  or 
(B) a PE-conjugated anti-IFN-~/ 
or control antibody, as described 
in  Materials  and  Methods. 
Brefeldin A was added or omit- 
ted for the last 2 h of stimulation, 
and IFN-'y was visualized  by flu- 
oresence  microscopy  (A)  or 
flow  cytometry  (B).  Neither 
Brefetdin-treated nor -untreated 
cells stained with the control an- 
tibody,  but  Brefeldin enhanced 
specific staining for IFN-"/. Simi- 
larly treated CDC25  cells (Th2) 
showed  no  specific staining for 
IFN-y with or without Brefeldin 
treatment (not shown). Cell flu- 
orescence was measured using a 
FACScan  |  and  quadrants were 
set  according  to  the  isotype- 
matched controls. Data were an- 
alyzed using Lysis  I1 software. 
kine synthesis at the single-cell level (Fig. 2).  This result is 
in agreement with data recently presented about analysis of 
IFN-',/ and  IL-4 mRNA  expression by DO11.10-derived 
clones, which shows a  low frequency of IL-4 mRNA  ex- 
pression by Th2  clones compared to  IFN-y expression by 
Thl  clones (30).  Specificity of staining of IFN-y and IL-4 
was shown  using isotype-matched controls (Fig. 2  D)  and 
by specific appropriate staining of Thl and Th2 clones (Fig. 
2 A-C). These controls were used to set threshold markers 
on flow cytometric plots as shown  (Fig. 2  D).  As a further 
control, Thl  and Th2  clones were mixed at different ratios 
(Fig.  2  A-C)  before  stimulation,  fixing,  and  staining  for 
IFN-y and IL-4, to show whether secreted cytokines could 
bind to the cell surface via specific receptors and give false 
results when  mixed populations were analyzed. Such  cell- 
surface staining would be characterized by cells staining for 
both  IFN-y  and  IL-4  within  mixtures  of Thl  or  Th2 
clones, which are known  to  express either IFN-y or IL-4 
alone.  This  clearly does  not  occur  (Fig.  2  A-C),  demon- 
strating  that  the  double-positive staining  for  IFN-3,  and 
IL-4 that is sometimes observed (see Figs. 4  and  6)  repre- 
sents true cosynthesis by individual cells. In addition, mix- 
ing of different ratios of Thl  and Th2  cells (e.g., Fig. 2  C, 
Thl/Th2  ratio is 6:94) demonstrates that even when as few 
as  1% of the cells in a population are expected to stain for 
IFN-y, they are still detectable by this method. 
The  observation  that  synthesis  of  intracellular  IFN-y 
could  be  detected  in  "-,100%  of  the  cells  within  Thl 
clones, whereas IL-4 producing cells were always at a lower 
frequency  within  Th2  clones,  prompted  us  to  investigate 
the kinetics of synthesis of each of the cytokines as a possi- 
ble  explanation  of this phenomenon.  Fig.  3  shows  repre- 
sentative  data  obtained  from  both  long-  and  short-term 
Thl  and Th2  clones (derived from single cells). Cells were 
stimulated  with  PMA  and  ionomycin  at  regular intervals 
for up to 24 h, and Brefeldin A was added for the last 2 h  of 
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Figure  2.  Specific two-color 
staining of Thl  and Th2  clones 
for  IFN-~  and  IL-4.  Thl  and 
Th2  clones were cultured sepa- 
rately or together,  as indicated, 
in IL-2 overnight before stimula- 
tion with PMA and ionomycin 
for 4 h in the presence of Brefel- 
din A for the last 2 h. Cells were 
fixed and stained for IFN-y and 
IL-4  synthesis as  described  in 
Materials  and  Methods.  (A) 
HDK-1  (Thl)  and  CDC25 
(Th2) cells alone or mixed in a 
50:50  ratio  before  overnight 
culture  (Thl  +  Th2).  (13) 
DO11.10-derived,  OVA-spe- 
cific Thl or Th2 clones alone or 
mixed in a 36:64 ratio (Thl  + 
Th2)  overnight.  (C)  More 
DOll.10-derived Thl  or  Th2 
clones alone or mixed in a 6:94 
ratio overnight (Thl +  Th2). In 
all  cases where  Thl  and  Th2 
clones were mixed before stimu- 
lation, <1.0%  cells stained dou- 
ble positive for both IFN-'y and 
IL-4, demonstrating the sensitiv- 
ity and specificity of the staining 
method  even under  the condi- 
tions of cocultivation. Cell fluorescence was measured using a FACScan  |  and quadrants were set according to the isotype-matched controls. (D) A rep- 
resentaive negative control, CDC25 (Th2), stained for anti-IFN-~ and GL113; all other controls were identical (not shown). Data was analyzed using Ly- 
sis II software, and they are displayed  as bivariate dot plots. Percentages of cells in each quadrant (set according to the negative controls) are shown in the 
top fight-hand corner of each panel. Levels of IFN-',/or IL-4 (ng/ml), measured in 48-h supernatants are shown in the boxes contained within each 
panel. 
stimulation. In long- and short-term clones, the peak ofin- 
tracellular synthesis of both  cytokines occured at r  h  of 
stimulation  (Fig.  3).  Whereas  IFN-~/  synthesis  by  Thl 
clones was  sustained throughout,  IL-4 synthesis was  rela- 
tively transient, and it declined rapidly straight after synthe- 
sis peaked at 4  h.  We show in Table  1 that both Thl  and 
Th2 clones are heterogeneous with respect to their phase in 
the  cell cycle after stimulation with PMA and ionomycin 
(as above) for various time intervals. Since mammalian cells 
such as these are not synchronously in cell cycle, it is inevi- 
table that ifa cytokine like IL-4 is transiently synthesized, it 
will never be detectable in 100% of cells simultaneously. 
Analysis  of Kinetics of Intracellular Synthesis  of IFN-3, and 
IL-4  by  Single Cells in  ThO  Clones Reveals  Cells Simulta- 
neously Producing Both  Cytokines.  Mouse  and  human  Th 
clones  that  produce  both  Thl-  and  Th2-type  cytokines 
have  been  described  (2-4,  6-8,  48,  49).  It  is  not  clear, 
however,  what the status of cytokine production by indi- 
vidual cells within  a  Th0  clone  is since  few  (33)  experi- 
ments  using  simultaneous  analyses of IFN-y  and  IL-4  in 
single cells have  been performed.  They could consist of a 
mixture of cells producing either only IFN-~/, only IL-4, or 
cells that are capable of producing both cytokines. We have 
analyzed a number of short-term Th0 clones obtained from 
the  DOl1.10  TCR-transgenic  mouse,  as  described  in 
Materials  and  Methods.  Two  representative  Th0  clones 
contained  individual  cells  synthesizing  IFN-y  or  IL-4 
exclusively,  or  both  cytokines  simultaneously,  while  the 
majority of the cells within the population often produced 
neither cytokine (Fig. 4). Many of the clones also produced 
much lower levels of both IFN-~/and IL-4 by immunoas- 
say  (data  not  shown)  than  polarized Thl  or  Th2  clones, 
which correlated with the low frequency of cells synthesiz- 
ing either IFN-',/or IL-4 intracellularly, or both cytokines 
simultaneously (Fig. 4).  Interestingly, the  IFN-y was  syn- 
thesized at a later stage in the Th0  clones  (Fig. 4)  than in 
the completely polarized Thl  clones (Fig. 3). Furthermore, 
this  later appearance  of IFN-y-producing cells correlated 
with  the  decline of IL-4 synthesis.  This  suggests  that  the 
synthesis of Thl-  and Th2-type cytokines in individual T 
cells may be mutually exclusive. 
Table 1.  Cell  Cycle Analysis of Th I and Th2 Clones 
Percentage ofceUs after 
stimulation (h) 
Stage of  T helper 
cell cycle  0  2  4  8  20  clone 
76  78  75  76  57  Thl 
G0-GI 
67  66  63  68  69  Th2 
15  13  19  17  14  Thl 
Ga-M 
12  12  14  12  20  Th2 
10  9  6  7  29  Thl 
S  21  22  23  20  11  Th2 
1361  Openshaw et al. _r 
1 
o 
0  ,> 
dBm 
=l  u) 
0 
a. 
# 
Ovalbumln-speclflc 
Clones 
100' 
80, 
60' 
40 
20 
Thl  clone 
4  12  20  28 
Th2 clone  I~ 
100 
8O 
40 
20 
0~-----  ~  --  -  ,  ==  -  ￿9  -  1  ,  - 
￿9  12  20  28 
Established 
Long-term Clones 
Thl  clone  [~] 
100 
8O 
6O 
4O 
2O 
O--  --  _  .  .  ￿9  .  ￿9  --  -  , 
4  12  20  28 
100 
80 
60 
40 
20 
Th2 clone 
O1  1  ~-=-l,  ~-. 
4  12  20  28 
time (h) 
Figure 3.  Kinetics of intracellular synthesis of IFN-'y 
and IL-4 in clones with polarized cytokine production. 
T  cell clones derived from single-ceil cukures were 
used for experiments 10--14 d after stimulation with 
antigen and irradiated splenic APC. These resting cells 
were washed and restimulated with PMA and ionomy- 
cin for various times, and Brefeldin A (10 p,g/ml) was 
added for the last 2 h.  (A and B) DOll.10-derived, 
OVA-specific, TCR-transgenic  Thl  and Th2 clones; 
(C and D) long-term Thl (HDK-1, KLH-specific) and 
Th2  (CDC25,  rabbit Ig~specific), respectively. Cells 
were fixed and stained for intraceUular IFN-3 and IL-4 
synthesis as described in Materials and Methods. Flow 
cytometric analysis  was as described in Fig. 2. O, IFN-~/; 
A, IL-4; I1, control. 
Similar Patterns of lntracellular Synthesis of lFN-'y and IL-4 
By  Th l  and  Th2  Clones after Stimulation with Either PMA 
and  Ionomycin or  Splenic APC Plus  Specific Antigen.  The 
reason  for using PMA  and ionomycin  rather  than  specific 
antigen was to reveal the full cytokine production potential 
of T  cells and try to minimize variability in kinetics result- 
ing  from  antigen  processing  and/or  presentation.  In  the 
case  of the  DOll.10-derived  clones,  it  could  be  argued 
that  the  use  of the  rnitogen  is  equivalent  to  stimulation 
with the peptide,  since all express high levels of the clono- 
type TC1K, as assessed by flow cytometric staining with the 
anticlonotype antibody (38). Although the aim of this study 
was to define the full potential of the differentiated Th cell, 
it was important to assess whether physiological stimulation 
would yield a response pattern similar to that which is seen 
after  mitogen  stimulation.  A  number  of Thl  and  Th2 
clones  derived  from  the  DOl1.10  TC1L-otl3  transgenic 
mouse were therefore analyzed after stimulation  with anti- 
gen and APC or with mitogen.  IntraceUular cytokine syn- 
thesis  was  similar  regardless  of the  type  of stimulation; 
however,  70% of the  Thl  cells stained positive for IFN-~/ 
synthesis after stimulation with PMA and ionomycin, com- 
pared to only up to 40% of the cells stimulated with splenic 
APC  and  peptide  antigen  (Fig.  5).  The staining was mar- 
ginalty  brighter  after  stimulation  with  the  mitogens.  In 
contrast,  the  frequency  of cells synthesizing IL-4 was usu- 
ally identical  after stimulation  with  specific antigen  or mi- 
togen. The difference in IFN-'y synthesis may be caused by 
differences  in  kinetics  resulting  from  different  modes  of 
stimulation, or by endogenous levels ofcytokines in splenic 
APC,  which  are suppressive for IFN-'y synthesis.  Thus,  in 
most  cases,  experiments  were  performed  in  parallel  with 
mitogen or APC  and specific antigens,  with both stimula- 
tions giving broadly similar results. 
Bulk Cultures of Naive CD4  + T  Cells Can  Be Induced to 
Develop into Polarized Thl  and  Th2  Populations Containing 
High  Frequencies of IFN-T-  or  IL-4-producing  Cells When 
Chronically Stimulated with Antigen in the Presence of lL-12 or 
IL-4.  CD4 + T  cells develop into Thl-  or Th2-type pop- 
ulations if stimulated with antigen in a primary response in 
the presence of IL-12 or IL-4, respectively (24--27, 29,  50, 
51). While this has been demonstrated by the analysis of se- 
creted IFN-~/or IL-4 (24-27, 29, 50, 51), little information 
is available regarding the  heterogeneity  of the  populations 
at the single-cell level. We demonstrate  that OVA-specific 
T  cells  from  the  TC1K-ot[3  transgenic  mouse  stimulated 
with splenic APC plus antigen for 1 wk resulted in a popu- 
lation in which  10% of the cells synthesized IL-4 intracellu- 
larly, but few cells produced  IFN-',/(<1%)  (Fig.  6). Addi- 
tion  of IL-4 in  primary cultures  led  to  a  slight increase  in 
IL-4-producing  cells  (14%).  Surprisingly,  a  small  number 
of IFN-~/-producing  cells could be detected,  half of which 
produced  IL-4 simultaneously  (Fig.  6).  In accordance with 
results obtained by measuring cytokine secretion by immu- 
noassay (not shown),  CD4 + T  cells stimulated  with  OVA 
in  the  presence  of IL-12 gave rise  to a  high  frequency  of 
IFN-'y-producing  cells  (87%),  but  no  IL-4-producing 
cells.  The frequency of IFN-~/-producing  cells was similar 
at  this  stage  when  anti-IL-4  mAbs  were  added  to  IL-12 
cultures. 
Since  many  of the  original  Thl  and  Th2  clones  de- 
scribed by Mosmann and Coffman (5) were obtained from 
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Figure 4.  Kinetics  ofintracellular  synthesis of IFN-~/and IL-4 by Th0 clones. Two representative DO11.10-derived, OVA-specific  Th0 clones derived 
from single-cell culture, as described in Materials and Methods, were used for experiments 10-14 d after stimulation with antigen and irradiated splenic 
APC. Resting cells were washed and restimulated with PMA and ionomycin  for various times, and Brefeldin A (10 p.g/ml) was added for the last 2 h. 
Cells were fixed and stained for IFN-3t  and IL-4 synthesis as described in Materials and Methods. Flow cytometric analysis  was as described in Fig. 2. 
-O-, IFN-'y; -A-, IL-4; -I1-, control. 
chronically  immunized  mice,  we  attempted to  drive  the 
development of a higher frequency of either IFN-~- or IL-4- 
producing  cells  by repeated  stimulation with  antigen  and 
APC  for three  consecutive  weeks in  the  presence  or ab- 
sence oflL-4, IL-12, or anti-IL-4 plus IL-12. T  cell popu- 
lations stimulated with antigen and APC only contained a 
high frequency of IL-4-producing cells  (83% compared to 
10%  after  the 1st  wk).  The  addition  of exogenous  IL-4 
during  the  3  wk  of stimulation  did  not  increase  the  fre- 
quency of IL-4-producing cells,  and the addition  of anti- 
IL-4 antibodies resulted in T  cell populations only produc- 
ing  IFN-%  suggesting  that  endogenous  IL-4  may  have 
caused this initial skewing towards a Th2 phenotype. Since 
the DOl1.10  mice are of a BALB/c genetic background, 
this may account for the development of a Th2 phenotype 
resulting from endogenous levels oflL-4 (52),  and may not 
always be the case with TCR  transgenic mice of different 
genetic backgrounds (26). Addition oflL-12 during the re- 
peated stimulation increased the frequency of cells produc- 
ing only IFN-~/, but it also led to the development of cells 
producing  both  IFN-'y and  IL-4  (3%).  In  some  experi- 
ments,  the  number  of  cells  simultaneously  synthesizing 
both  IFN-~/  and  IL-4 was  higher  (5%).  The  observation 
that  no  cells  develop  producing  both  IFN-~/  and  IL-4 
when  cells  were  chronically stimulated  with  antigen  and 
APC in the presence of IL-12 plus neutralizing antibodies 
directed  against  IL-4 reflects the  presence of endogenous 
IL-4. These data suggest that the development of double- 
producing  cells  is  determined  by the  dual  action  of IL-4 
and  IL-12 during  antigenic  stimulation,  and that the per- 
centage  of these  cells  developing depends  strictly  on  the 
relative levels oflL-4 and IL-12 in the cultures. Cultures of 
CD4 + T  cells containing IL-4 (either endogenous or exog- 
enous)  initially  proliferated  more  vigorously  than  other 
groups  stimulated  with  antigen  and  APC.  It is  not  clear 
whether the differentiation of naive CD4 + T  cells into Th2 
cells is linked to this proliferation. However, we have data 
to support that Th2 cells differentiate from a single cell and 
do  not  result  from clonal  expansion  of a  subpopulation. 
Briefly, culturing of single naive CD4 + T  cells obtained by 
FACS  |  on irradiated splenic APC, plus OVA peptide, plus 
IL-2 and IL-4 results in up to 80% cloning efficiency, and 
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Figure  5.  Comparison of intraceUular synthesis of IFN-~/ or IL-4 after 
stimulation with  specific  antigen  or  PMA  and  ionomycin.  DOll.10- 
derived, OVA-specific Thl  (top panel)  or Th2 (bottom panel)  clones were 
stimulated with irradiated splenic APC plus OVA (left-hand side) or with 
PMA and ionomycin for 4 h, with Brefeldin A added for the last 2 h be- 
fore fixing and staining for IFN-"/and IL-4 as described in Materials and 
Methods. Celi fluorescence was measured using a  FACScan  |  and quad- 
rants were set according to the isotype-matched controls. Data was ana- 
lyzed using Lysis II software, and they are displayed as bivariate dot plots. 
Percentages of cells in each quadrant (set according to the negative con- 
trois)  are  shown in the top  right-hand comer of each panel.  Levels of 
IFN-y or IL-4 (ng/ml) measured in 48-h supematants are shown in the 
boxes contained within each panel. 
all the resulting populations are of the Th2 type (Murphy, 
E.,  and  A.  O'Garra,  unpublished  observation).  Although 
initial  stimulation  of bulk cultures  of naive  CD4 + T  cells 
with  antigen  and  APC  in  the  presence  of IL-4  intially 
shows  increased  proliferation,  repeated  stimulation  with 
antigen in the presence of IL-4 leads to a rapid decline in 
the cell recoveries (Table 2),  suggesting that Th2 cells may 
lose  their proliferative  capacity as  they  differentiate.  This 
trend  can also be seen with Thl  cells,  but  this  decline  in 
proliferation  is  more  gradual,  and  initial  cultures  do  not 
show the dramatic proliferation that is seen in cultures con- 
taining IL-4 (Table 2). 
In summary, stimulated Thl clones show prolonged syn- 
thesis of IFN-y so that ~-,100% of the population is seen to 
Table  2.  Expansion  of OVA-specific  CD4 +  T  Cells 
Stimulation  1 wk  2  wk  3  wk 
--  57  30  9 
IL-4  38  28  4 
IL-12  10  25  11 
Anti-lL-4  +  IL-12  10  22  11 
Anti-tL-4 mAb  28  17  5 
Stimulation of CD4  + 
T  Cells + OVA and Splenic 
APC for: 
Medium 
Alone 
IL-4 
IL-12 
Anti-lL4 
Anti-lL4 
+1L-12 
1 wk  3 wk 
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Figure  6.  Intracellular synthesis of IFN-y and IL-4 by Thl- and Th2- 
type populations derived from naive CD4 + T  cells stimulated with anti- 
gen and APC in the presence oflL-12 or IL-4. Transgenic CD4 + T  cells 
(2.5 X  105 per well) prepared from DO11.10 mice were cultured in 2-ml 
volumes in 24-well  plates with  irradiated  splenic APC  (2.5  ￿  106 per 
well)  and peptide  (0.3  laM).  During primary stimulation, cultures con- 
tained the conditions as stated: no additions, IL-4 (200 U/nil), IL-12 (10 
U/ml),  anti-lL-4 mAb  (10  lag/m/),  or [L-12  (10 U/m/) plus anti IL-4 
mAb  (10  lag/m/).  After 7  d  (left-hand panels),  cells in primary  cultures 
were harvested, washed, and restimulated with PMA and ionomycin for 
4  h  with Brefeldin A  added for the last 2  h.  Cells were then fixed and 
stained for intracellular staining of IFN-y and IL-4 as described in Materi- 
als and Methods. Alternatively,  cells were stimulated once per week for 3 wk 
under the above conditions, and then harvested, stimulated, and stained as 
described above (right-hand panels).  Cell fluorescence was measured using 
a  FACScan  |  and quadrants were  set according to  the isotype-matched 
controls. Data was analyzed using Lysis II software, and they are displayed 
as bivariate dot plots. Percentages of cells in each quadrant (set according 
to the negative controls) are shown in the top right-hand comer of each 
panel. Levels oflFN-"/or IL-4 (ng/ml) measured in 48-h supernatants are 
shown in the boxes contained within each panel. 
be positive for IFN-y by flow cytometry. In contrast, stim- 
ulation  of Th2  clones results in transient IL-4 synthesis so 
that only ~40% of the cells can be shown to synthesize IL-4 
at  any  one  time.  Although  this  could  be  interpreted  as 
showing heterogeneity of cells  within  the  population,  we 
argue  that this  could alternatively be interpreted by tran- 
sient synthesis of IL-4 by nonsynchronously cycling mam- 
malian cells.  Th0 cells  often show relatively low numbers 
of cells expressing IFN-y or IL-4 exclusively, as well as low 
1364  Heterogeneity of Intracellular Cytokine Production by CD4 + T  Ceils numbers of cells producing both cytokines simultaneously. 
Interestingly,  IFN-~/  appears  as  synthesis  of IL-4  dimin- 
ishes, suggesting that IFN-~/synthesis may be regulated by 
IL-4.  It is possible  that  different  Th0  clones  may vary in 
their  relative  levels of Thl  versus  Th2  cytokines,  and the 
respective level of either type will determine whether their 
role  in  the  outcome  of an  immune  response  is  to  direct 
more of a cell-mediated-type  or a humoral-type response. 
We show also  that  chronic  stimulation  of naive  CD4 +  T 
cells in the presence of polarizing stimuli, can result in high 
frequencies  of Thl-  or Th2-type  cells  (producing  exclu- 
sively IFN-~/or IL-4, respectively)  and a reduction in cells 
that do not produce either IFN-~/or IL-4. The presence of 
IL-4  together  with  IL-12  during  repeated  stimulation, 
however,  also  gives rise  to  cells  synthesizing both  IFN-~/ 
and  IL-4.  These  data  confirm at  the  single-cell  level that 
IL-12 and  IL-4 are  strong polarizing  stimuli  for Thl  and 
Th2  development  from  naive  CD4 +  T  cells,  and  they 
demonstrate  that a large number of cells  in the population 
have the exclusive capacity to produce IFN-~/or IL-4 after 
activation.  It is possible that many chronic conditions may 
cause  the  emergence  of polarized  Thl-  or Th2-type  im- 
mune responses that are mutually exclusive, perhaps in part 
because of counterinhibitory effects of cytokines on the re- 
ciprocal Th subset. 
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